A version of this story originally appeared on Pharmaceutical Technology.
As clinical trials grow more complex, the ability to rescue a struggling study hinges not just on technology, but on the strength of your CDMS partner’s support services. When timelines are tight and data integrity is at risk, having a clinical data management platform with responsive, expert support can mean the difference between failure and recovery.
That was the case for Fractyl Health in mid-2024, when Director of Data Management LeRoy Stafford was tasked with rescuing a high-stakes Phase II trial that had changed hands multiple times over five years. The study faced mounting challenges: a protocol amendment days from release, a new internal team still onboarding, and a backlog of CRFs requiring urgent setup.
Stafford needed a CDMS that could adapt fast—and a partner that could guide his team through the chaos. Zelta delivered both.
Implementing Zelta for their clinical trials allowed Fractyl to:
Most importantly, it gave Fractyl access to a 24/7 services team that didn’t just respond – they anticipated. Our team flagged issues early, advised on best practices, and helped Fractyl go live on their study in just four weeks, a timeline that exceeded internal expectations and earned praise from senior leadership.
“I needed a system flexible enough to split a complex protocol into a clean, manageable study. Zelta was my first choice. It’s nimble enough for in-house tailoring, but robust enough to offer real-time support.”
-- LeRoy Stafford, Director of Data Management, Fractyl Health
For executives overseeing clinical operations, this case underscores a key insight: support services are not ancillary—they’re strategic. In high-risk, high-complexity environments, the ability to pivot quickly depends on:
“Flexibility isn’t just about what your technology does in a crisis. It’s about how you plan and collaborate before the crisis arises.”
-- LeRoy Stafford, Director of Data Management, Fractyl Health
Fractyl’s experience with Zelta has reshaped its approach to study design. Going forward, the team is embedding cross-functional input and risk-based planning from day one, minimizing the need for future rescues.
For pharma leaders, the takeaway is clear: when selecting a CDMS partner, prioritize support services as a core capability. The right partner won’t just provide a platform—they’ll help you deliver, even under pressure.
Clinical trials face increasing challenges, from rising costs and complex protocols to maintaining site and participant engagement. Don’t let these obstacles slow down your research timelines or impact your business goals.
Our whitepaper, “Confidence in clinical trials amid complexity and change,” dives into our industry’s most pressing challenges and offers actionable solutions for CROs and sponsors like you to streamline your clinical trials and boost ROI.
Your resource for smarter trials is a click away. Read the whitepaper to learn more.